← Leaderboards
Li Xu
Revopsis Therapeutics, Inc.
$1,867,066
Attributed
$1,867,066
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $933.5K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,867,066 · 1
By mechanism
R44$1,867,066 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Adherence”
- Dennis Eyler · Fisher Bioservices, Inc.$16,341,540
- Matthew Morrow Engelhard · Duke University$7,519,665
- Andrew Gardiner · Libero Pharma Limited$6,351,015
- Richard Schrock · Fisher Bioservices, Inc.$5,879,422
- Christopher J. Lindsell · Vanderbilt University Medical Center$5,384,363
- Charles Daniel Meyers · Tempero Bio, Inc.$5,310,920
Research focus
AdherenceAffectAffinityAge Related Macular DegenerationAging PopulationAmericanAngiopoietin-2Animal ModelAnimalsAntibodiesAreaAwarenessBackBevacizumabBindingBiologicalBiological ProcessBlindnessBloodBlood Chemical AnalysisBlood VesselsCaringChemistryAccounting